Literature DB >> 14252283

MANAGEMENT OF THYROTOXICOSIS IN PATIENTS WITH OPHTHALMOPATHY: ANTITHYROID REGIMEN DETERMINED PRIMARILY BY OCULAR MANIFESTATIONS.

H ARANOW, R M DAY.   

Abstract

Entities:  

Keywords:  DRUG THERAPY; EYE MANIFESTATIONS; GOITER, EXOPHTHALMIC; HYPERTHYROIDISM; IODINE ISOTOPES, THERAPEUTIC; THYROID ANTAGONISTS; THYROIDECTOMY

Mesh:

Substances:

Year:  1965        PMID: 14252283     DOI: 10.1210/jcem-25-1-1

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  13 in total

Review 1.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

2.  Ocular manifestations of Graves' disease: therapeutic approaches.

Authors:  R M Day
Journal:  Bull N Y Acad Med       Date:  1977-04

Review 3.  Hyperthyroidism.

Authors:  P Kendall-Taylor
Journal:  Br Med J       Date:  1972-05-06

4.  Endocrine exophthalmos.

Authors:  M C Bateson
Journal:  Br Med J       Date:  1972-10-07

Review 5.  Total thyroid ablation in Graves' orbitopathy.

Authors:  F Menconi; M Leo; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

6.  [Endocrine ophthalmopathy in Graves disease during antithyroid drug therapy (author's transl)].

Authors:  H Wuttke; D Schlieter; F Krück
Journal:  Klin Wochenschr       Date:  1979-01-15

7.  The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine.

Authors:  N Bromberg; J H Romaldini; R S Werner; J A Sgarbi; M C Werner
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

Review 8.  Prevalence and natural history of Graves' orbitopathy in the XXI century.

Authors:  E Piantanida; M L Tanda; A Lai; L Sassi; L Bartalena
Journal:  J Endocrinol Invest       Date:  2013-04-16       Impact factor: 4.256

9.  Dysthyroid ophthalmopathy: an update.

Authors:  L A Young
Journal:  J Natl Med Assoc       Date:  1979-09       Impact factor: 1.798

Review 10.  Graves' ophthalmopathy.

Authors:  J R Wall; J Henderson; C R Strakosch; D M Joyner
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.